EW
EMN icon

Evoke Wealth’s Eastman Chemical EMN Stock Holding History

Evoke Wealth’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-171
Closed -$12K – 609
2022
Q3 		$12K Sell
171
-18
-10% -$1.62K ﹤0.01% 720
2022
Q2 		$17K Buy
189
+147
+350% +$15.2K ﹤0.01% 680
2022
Q1 		$5K Hold
42
– – ﹤0.01% 898
2021
Q4 		$5K Hold
42
– – ﹤0.01% 890
2021
Q3 		$4K Sell
42
-30
-42% -$3.31K ﹤0.01% 882
2021
Q2 		$8K Sell
72
-15
-17% -$1.8K ﹤0.01% 775
2021
Q1 		$10K Buy
87
+45
+107% +$4.89K ﹤0.01% 689
2020
Q4 		$4K Hold
42
– – ﹤0.01% 759
2020
Q3 		$3K Hold
42
– – ﹤0.01% 765
2020
Q2 		$3K Buy
42
+12
+40% +$756 ﹤0.01% 782
2020
Q1 		$1.4K Sell
30
-3
-9% -$193 ﹤0.01% 875
2019
Q4 		$2.64K Hold
33
– – ﹤0.01% 1030
2019
Q3 		$2.46K Buy
+33
New +$2.37K ﹤0.01% 1166

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Evoke Wealth's EMN Position: Q4 2022 in Review

Evoke Wealth sold out of Eastman Chemical (EMN) in Q4 2022, closing a stake of 171 shares — an estimated $12K sold.

Evoke Wealth first reported a position in EMN in Q3 2019 and held it in 13 quarters. The position peaked at $17K in Q2 2022. 706 funds tracked by Wall St. Rank hold EMN as of Q4 2022.

  • Evoke Wealth reported no remaining Eastman Chemical position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 171 Eastman Chemical shares in Q4 2022, an estimated $12K.
  • Evoke Wealth first reported a position in Eastman Chemical in Q3 2019 and held it in 13 quarters.
  • Evoke Wealth's Eastman Chemical position peaked at $17K in Q2 2022.
  • 706 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.